Nocdurna

Active Ingredient(s): Desmopressin Acetate
FDA Approved: * June 21, 2018
Pharm Company: * FERRING PHARMS INC
Category: Diabetes

Desmopressin, sold under the trade name DDAVP among others, is a medication used to treat diabetes insipidus, bedwetting, hemophilia A, von Willebrand disease, and high blood urea levels.[1] In hemophilia A and von Willebrand disease, it should only be used for mild to moderate cases.[1] It may be given in the nose, by injection into a vein, by mouth, or under the tongue.[1] Common side effects include headaches, diarrhea, and low blood sodium.&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Nocdurna 27.7 ug/1 Sublingual Tablet
NDC: 54436-325
Labeler:
Antares Pharma, Inc.
Nocdurna 55.3 ug/1 Sublingual Tablet
NDC: 54436-350
Labeler:
Antares Pharma, Inc.
Nocdurna 27.7 ug/1 Sublingual Tablet
NDC: 55566-5050
Labeler:
Ferring Pharmaceuticals Inc.
Nocdurna 55.3 ug/1 Sublingual Tablet
NDC: 55566-5070
Labeler:
Ferring Pharmaceuticals Inc.

Related Brands

Drugs with the same active ingredients